Previous Page  11 / 12 Next Page
Information
Show Menu
Previous Page 11 / 12 Next Page
Page Background

allied

academies

Page 33

Notes:

June 06-07, 2019 | London, UK

2

nd

International Conference on

Tissue Science and Molecular Biology,

Stem Cells & Separation Techniques

Joint Event

Biomedical Research (An International Journal of Medical Sciences) | ISSN: 0976-1683 Volume 30

An automated perfusion bioreactor system for oxygen-controlled cultivation of 3D-cell

cultures

Jakob Schmid

Munich University of Applied Sciences, Germany

B

ioreactor systems are an important factor for the

successful cultivation of 3D-cell cultures, since they

are able to overcome limitations of static cell culture, by

providing proper nutrient and oxygen levels. A bioreactor,

which is suitable for the reproducible generation of tissue

engineered grafts (TEGs), as well as for the optimization

of culture conditions, has to meet several requirements,

such as built-in measurement instrumentation and control

technology, high throughput and high flexibility. In the

present study, a perfusion bioreactor system, which allows

for the oxygen-controlled cultivation of up to four TEGs in

independently operating bioreactors, was designed and

manufactured using rapid prototyping technologies. A

uniform flow distribution in the developedmicrobioreactor

was shown using computational fluid dynamics. The

integrated measurement instrumentation and control

technology allows for the cultivation at pre-set oxygen

levels. Furthermore, an automated cell-seeding protocol

ensures a homogeneous initial cell distribution and thus

a reproducible workflow. The developed microbioreactor

system opens up new possibilities in the field of tissue

engineering by enabling more reproducible experiments,

the investigation of optimal oxygen levels in 3D cell cultures

and by allowing for the generation of artificial tissue in an

oxygen-controlled environment.

Speaker Biography

Jakob Schmid is a PhD student at the center of applied tissue engineering

and regenerative medicine (CANTER) at the Munich University of Applied

Sciences. He earned his BSc in biotechnology at the Weihenstephan

UniversityofAppliedSciencesandhisMSc inpharmaceuticalbiotechnology

at the UlmUniversity. CANTER is a cooperative research lab of the Technical

University Munich, the Ludwig-Maximilians-University Munich and the

Munich University of Applied Sciences. The main focuses of CANTER are to

investigate methods of three-dimensional printing for tissue engineering

to open new possibilities and applications for tissue engineering research

and to characterize tissue and cell-cell interactions on a biophysical

level to increase knowledge about macromolecular functions in tissue.

e:

jakob.schmid0@hm.edu

Jakob Schmid

, Biomed Res, Volume 30

ISSN: 0976-1683